⌘K
t
Hikma Pharmaceuticals PLC announced on 13 August 2025 that Susan Ringdal, a Person Discharging Managerial Responsibility (PDMR), exercised nil-cost share options under the 2014 Executive Incentive Plan. This resulted in her acquisition of 60,225 ordinary shares at a nil price on 12 August 2025. On the same date, Ms. Ringdal sold 28,393 ordinary shares at £17.76 per share, totaling £504,191.77, to cover tax obligations.
| Date | 13 Aug 2025 |
| Time | 13:51:22 |
| Category | Director/PDMR dealings |
| ID | 2177V |
Hikma Pharmaceuticals PLC - PDMR Exercise of Share Awards
LONDON, 13 April 2025: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Person Discharging Managerial Responsibility ("PDMR") has received shares and sold sufficient to cover tax as a result of the exercise of options granted at nil-cost on 17 March 2016, 13 April 2017 and 16 May 2018 under the 2014 Executive Incentive Plan ("EIP").
Notification and public disclosure of transactions by persons discharging managerial responsibilities
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
||
|
a) |
Name |
Susan Ringdal |
|
|
2 |
Reason for the notification |
||
|
a) |
Position/status |
PDMR |
|
|
b) |
Initial notification /Amendment |
Initial notification |
|
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
|
a) |
Name |
Hikma Pharmaceuticals PLC |
|
|
b) |
LEI |
549300BNS685UXH4JI75 |
|
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
|
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
|
|
b) |
Nature of the transaction |
Acquisition of Shares pursuant to the exercise of options granted at nil-cost under the EIP |
|
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
Nil |
60,225 |
||
|
d) |
Aggregated information |
Price(s): nil Volume(s): 60,225 |
|
|
e) |
Date of the transaction |
12 August 2025 |
|
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
|
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
|
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
|
|
b) |
Nature of the transaction |
Shares sold to cover tax following the exercise of options granted at nil-cost under the EIP. |
|
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
£17.76 |
28,393 |
||
|
d) |
Aggregated information |
Price(s): £17.76 Volume(s): 28,393 Total(s): £504,191.77 |
|
|
e) |
Date of the transaction |
12 August 2025 |
|
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
|
Helen Middlemist
Group Company Secretary
+44 (0)20 7399 2760